UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT of 1934 For the quarterly period ended June 30, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT of 1934 For the transition period from to Commission File Number 000-30833 BRUKER CORPORATION (Exact name of registrant as specified in its charter) Delaware 04-3110160 (State or other jurisdiction of incorporati ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT of 1934 For the quarterly period ended March 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT of 1934 For the transition period from to Commission File Number 000-30833 BRUKER CORPORATION (Exact name of registrant as specified in its charter) Delaware 04-3110160 (State or other jurisdiction of incorporat ...

Bruker Corporation (NASDAQ:BRKR) Q1 2022 Earnings Conference Call May 4, 2022 8:30 AM ET Company Participants Justin Ward - Senior Director of Investor Relations and Corporate Development Frank Laukien - Chairman, President and Chief Executive Officer Gerald Herman - Executive Vice President and Chief Financial Officer Conference Call Participants Puneet Souda - SVB Leerink LLC Brandon Couillard - Jefferies & Co. Joshua Waldman - Cleveland Research Patrick Donnelly - Citigroup Inc. Jack Meehan - Nephron Res ...

Bruker Corporation (NASDAQ:BRKR) Cowen's 42nd Annual Health Care Conference March 7, 2022 2:50 PM ET Company Participants Gerald Herman - EVP, CFO Conference Call Participants Max Masucci - Cowen Max Masucci Hi. Good afternoon. Welcome to Cowen's 42nd Annual Health Care Conference. I'm Max Masucci from Cowen's Life Science and Diagnostic Tools Research Team. We're pleased to be joined today by Bruker, which is one of the 3 large cap names in our coverage and a diversified participant in several life science ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT of 1934 For the fiscal year ended December 31, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 000-30833 BRUKER CORPORATION (Exact name of registrant as specified in its charter) Delaware 04-3110160 (State or other jurisdiction of Incorporation or organization)( ...

Bruker Corporation (NASDAQ:BRKR) Q4 2021 Earnings Conference Call February 11, 2022 8:30 AM ET Company Participants Frank Laukien - President & Chief Executive Officer Justin Ward - Senior Director of Investor Relations and Corporation Development Gerald Herman - Executive Vice President & Chief Financial Officer Conference Call Participants Dan Leonard - Wells Fargo Patrick Donnelly - Citi Puneet Souda - SVB Leerink Jack Meehan - Nephron Research Derik DeBruin - Bank of America Josh Waldman - Cleveland Res ...

Table of Contents Title of each classTrading Symbols(s)Name of each exchange on which registered Common Stock BRKR Nasdaq Global Select Market Emerging growth company ☐ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT of 1934 For the quarterly period ended September 30, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT of 1934 For the transition period from ...

Bruker Corporation (NASDAQ:BRKR) Q3 2021 Earnings Conference Call November 1, 2021 4:30 AM ET Â Company Participants Miroslava Minkova - Senior Director, Investor Relations and Corporate Development Frank Laukien - President and CEO Gerald Herman - Executive Vice President and CFO Conference Call Participants Puneet Souda - SVB Leerink Mike Ryskin - Bank of America Rachel Vatnsdal - JPMorgan Dan Arias - Stifel Sung Ji Nam - BTIG Josh Waldman - Cleveland Research Jack Meehan - Nephron Research Matt Sykes - G ...

Table of Contents Title of each classTrading Symbols(s)Name of each exchange on which registered Common Stock BRKR Nasdaq Global Select Market UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT of 1934 For the quarterly period ended June 30, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT of 1934 For the transition period from to Commission File Number 000- ...

Bruker Corporation (NASDAQ:BRKR) Q2 2021 Earnings Conference Call August 2, 2021 4:30 PM ET Â Company Participants Miroslava Minkova - Senior Director, Investor Relations and Corporate Development Frank Laukien - President and Chief Executive Officer Gerald Herman - Executive Vice President and Chief Financial Officer Conference Call Participants Puneet Souda - SVB Leerink Derik De Bruin - Bank of America Tycho Peterson - JPMorgan Dan Leonard - Wells Fargo Jack Meehan - Nephron Research Doug Schenkel - Cowe ...